Practice Areas

Healthcare, Life Sciences & Pharmaceuticals

Back

We act for clients at all stages of development of their products and services, and in all regulatory, commercial, and contractual matters. Our regulatory know-how, focus on the product, and multidisciplinary teams enable us to deal with the complex issues of this industry, by identifying and building the best solutions.

Our multidisciplinary healthcare, life sciences and pharmaceutical team acts in all legal areas relating to the health sector.

We handle important operations and support the development of strategic partnerships, acquisitions, and structural investments in this sector. Our team advises private companies and groups on a wide variety of commercial agreements, including manufacturing, supply, distribution, licensing, co-development, and product marketing agreements. We also help clients with agreements to transfer marketing authorisations, intellectual property rights and other assets.

We have advised clients on a broad range of regulatory and compliance issues in different jurisdictions. Our advice has covered prices, prior medical assessments, reimbursements, clinical trials, European certifications, statements of responsibility, pharmacovigilance, advertising, and data protection. Our team provides support in various markets and with various health regulators. This advice covers everything from medicines, medical devices, food supplements, borderline products, controlled substances, and healthcare to new technologies for prevention, diagnosis, and treatment, including e-health projects. Whatever the matter, we help companies and organisations to anticipate regulatory risks, to define effective strategies and to achieve their business goals.

We deal with all types of administrative licensing, for manufacturers, distributors, and retailers, and at all stages of the product cycle. The team also represents clients in the growing area of public procurement for health products and services, and it has extensive experience in the field of debt recovery.

We also advise the industry on evaluating, defining, and handling strategies to protect intellectual property, including trade and industrial secrets, and exclusive rights. In addition, our team assists its clients with the resolution of disputes, and it acts in the fields pre-litigation, litigation, and arbitration.

I appreciate the firm’s timing and availability and its clear and straightforward advice, as well as its expertise on the matter and its relationship with the public authorities.
Other Awards
2024 LMG Life Sciences Awards 2024 Non-IP Litigation Rising Star
2023 Life Sciences Europe Awards Life Sciences Europe Awards
2022 Life Sciences Awards 2022 EMEA
2022 Life Sciences Awards 2022 EMEA
2020 Forty under 40
2020 Forty under 40
2024 Life Sciences Europe Awards Life Sciences Europe Awards
2024 Life Sciences Europe Awards Life Sciences Europe Awards
2024 Life Sciences Europe Awards Life Sciences Europe Awards
2024 Life Sciences Europe Awards Life Sciences Europe Awards
Chambers Europe
2024 Life Sciences Recommended Tier 1
2023 Life Sciences Recommended Tier 1
2022 Life Sciences Recommended Tier 1
2021 Life Sciences Recommended Tier 1

"The team is very dedicated and swiftly reply to our queries. They are interested, proactive and enthusiastic - they identify a problem and simultaneously present a strategy to overcome it."

2020 Life Sciences Recommended Tier 1

"The team is very dedicated and swiftly reply to our queries. They are interested, proactive and enthusiastic - they identify a problem and simultaneously present a strategy to overcome it."

2019 Life Sciences Recommended Tier 1

"Clients are impressed by the team's very broad, strategic vision of life science issues and also the department's "great support" and underline its capabilities in regulatory matters."

2018 Intelectual Property - Life Sciences Recommended Tier 2

"Top-tier practice especially recognised in the market for copyright and trade mark matters. Also strong in unfair competition, licensing agreements and patent issues, including litigation."

Please note, your browser is out of date.
For a good browsing experience we recommend using the latest version of Chrome, Firefox, Safari, Opera or Internet Explorer.